These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16889078

  • 1. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.
    Grases F, Isern B, Perelló J, Sanchis P, Prieto RM, Costa-Bauzà A.
    Pharmazie; 2006 Jul; 61(7):652. PubMed ID: 16889078
    [Abstract] [Full Text] [Related]

  • 2. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
    Grases F, Isern B, Perelló J, Sanchis P, Prieto RM.
    Front Biosci; 2005 Jan 01; 10():799-802. PubMed ID: 15569619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of concomitant food intake on the excretion of orally administered myo-inositol hexaphosphate in humans.
    Grases F, Costa-Bauza A, Perelló J, Isern B, Vucenik I, Valiente M, Muñoz JA, Prieto RM.
    J Med Food; 2006 Jan 01; 9(1):72-6. PubMed ID: 16579731
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dietary myo-inositol hexaphosphate prevents dystrophic calcifications in soft tissues: a pilot study in Wistar rats.
    Grases F, Perelló J, Prieto RM, Simonet BM, Torres JJ.
    Life Sci; 2004 May 21; 75(1):11-9. PubMed ID: 15102518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lactic acid and thermal treatments trigger the hydrolysis of myo-inositol hexakisphosphate and modify the abundance of lower myo-inositol phosphates in barley (Hordeum vulgare L.).
    Metzler-Zebeli BU, Deckardt K, Schollenberger M, Rodehutscord M, Zebeli Q.
    PLoS One; 2014 May 21; 9(6):e101166. PubMed ID: 24967651
    [Abstract] [Full Text] [Related]

  • 12. Intake of myo-inositol hexaphosphate and urinary excretion of inositol phosphates in Wistar rats: Gavage vs. oral administration with sugar.
    Grases F, Costa-Bauzá A, Berga F, Gomila RM, Martorell G, Martínez-Cignoni MR.
    PLoS One; 2019 May 21; 14(10):e0223959. PubMed ID: 31626632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dietary inositol hexakisphosphate, but not myo-inositol, clearly improves hypercholesterolemia in rats fed casein-type amino acid mixtures and 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane.
    Okazaki Y, Katayama T.
    Nutr Res; 2008 Oct 21; 28(10):714-21. PubMed ID: 19083479
    [Abstract] [Full Text] [Related]

  • 19. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis.
    Grases F, Perelló J, Isern B, Prieto RM.
    Br J Dermatol; 2005 May 21; 152(5):1022-5. PubMed ID: 15888163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.